These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3398423)

  • 1. [Changes in blood composition during hemosorption in patients with terminal stage of chronic renal failure].
    Maksimenko VA; Belorusov OS; Panchina OI; Noskova LA; Marchenko AL
    Khirurgiia (Mosk); 1988 Apr; (4):85-8. PubMed ID: 3398423
    [No Abstract]   [Full Text] [Related]  

  • 2. [The duration of hemosorption in patients with chronic renal failure].
    Maksimenko VA; Belorusov OS; Gorbovitskiĭ EV; Mikhaĭlov IuE; Lanskaia IM
    Vestn Khir Im I I Grek; 1988 Jan; 140(1):134-6. PubMed ID: 3381390
    [No Abstract]   [Full Text] [Related]  

  • 3. [The morphological characteristics of the erythrocytes during hemosorption in patients with chronic kidney failure and suppurative intoxication].
    Samoĭlov MV; Danilkov AP; Kudriavtsev IuV; Naumov AG
    Urol Nefrol (Mosk); 1993; (1):34-7. PubMed ID: 7941124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
    Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of the blood prekallikrein-kallikrein system of patients with terminal kidney failure as affected by hemosorption].
    Petrun' NM; Baran EIa; Krimkevich EI
    Urol Nefrol (Mosk); 1986; (6):41-4. PubMed ID: 2433828
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
    Ender LA; Lagutina TS; Cherniakov VL; Shcherbakova EO; Shcherbakov VA
    Urol Nefrol (Mosk); 1984; (5):57-62. PubMed ID: 6095507
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
    Kozlov VV; Riabov SI; Dorofeeva TB; von Appen K; Spiridonov VN
    Ter Arkh; 1984; 56(7):77-81. PubMed ID: 6484840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extracorporeal hemosorption, an effective means of controlling exogenous and endogenous intoxications].
    Vlasenko AN
    Klin Med (Mosk); 1980 Jun; 58(6):17-22. PubMed ID: 6995710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of extracorporeal dialysis on the blood copper concentration and its relation to the hemoglobin level in patients with chronic renal failure].
    Weyde W; Adamiec R
    Pol Tyg Lek; 1983 Jan; 38(2):51-4. PubMed ID: 6856498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in biochemical and hematological indices during hemosorption in the acute period of the crush syndrome].
    Mikaelian NP; Ul'ianov MI; Muranov OF
    Biull Eksp Biol Med; 1984 May; 97(5):551-4. PubMed ID: 6722329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Level of serum immunoglobulins and circulating immune complexes in patients with terminal kidney failure during hemosorption treatment].
    Drannik GN; Baran EIa; Dem'ianova TV; Osnadchuk LN
    Vrach Delo; 1985 Aug; (8):86-8. PubMed ID: 4072118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency].
    Strel'nikova VA; Mochalova TP
    Probl Tuberk; 1985; (9):48-50. PubMed ID: 4070221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of hemosorption in chronic kidney failure].
    Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
    Klin Med (Mosk); 1984 Jun; 62(6):50-6. PubMed ID: 6471799
    [No Abstract]   [Full Text] [Related]  

  • 14. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA; Chudnovskaia MV; Golovanov SA
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of serum lipid and protein composition in patients with chronic renal failure].
    Markiewicz K; Walasek L; Lutz W
    Pol Tyg Lek; 1972 Jan; 27(4):131-3. PubMed ID: 5010168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
    Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hemosorption on indices of natural resistance in chronic kidney failure].
    Drannik GN; Dem'ianova TV; Seniuk OF; Siniĭchuk KhV; Gurinovich EA
    Vrach Delo; 1989 Jan; (1):16-8. PubMed ID: 2718434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemosorption in clinical practice (review of the literature)].
    Ananchenko VG; Griaznova NA; Glukhovskaia NIa; Kravets TA; Gulevich NV
    Sov Med; 1981; (2):72-7. PubMed ID: 7017955
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-molecular compounds in the erythropoietic disorder of patients in the terminal stage of chronic kidney failure].
    Gudim VI; Sukiasova TG; Ivanova VS; Gorbunova NA; Kozinets GI
    Patol Fiziol Eksp Ter; 1985; (6):66-71. PubMed ID: 4094808
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemosorption as a method of treating patients with chronic renal failure].
    Shumakov VI; Levitskiĭ ER; Dmitriev AA; Sakharov NN
    Sov Med; 1977 Oct; (10):95-9. PubMed ID: 929280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.